生物素标记人VEGF R1/FLT-1蛋白(Human VEGF R1/FLT-1 Protein)(93132ES)
产品应用
VEGFR1, also called Flt-1, is a 180 kDa type I transmembrane glycoprotein in the class III subfamily of receptor tyrosine kinases (RTKs). Human VEGFR1 ECD shares 78%, 78%, 84%, 87%, and 90% aa sequence identity with mouse, rat, porcine, canine and equine VEGFR1, respectively. VEGFR1 is up regulated during hypoxia, and participates in neovascularization and wound healing. VEGFR1 engagement on monocyte/macrophage lineage cells enhances their migration, and release of growth factors and cytokines. Lymphangiogenesis, angiogenesis, and growth-promoting effects of VEGFR1 are thought to result from enhanced migration of macrophages from the bone marrow to tumors and tissues where they recruit endothelial progenitors.
高纯度、高活性、低内毒素、高批间一致性

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
300
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
306
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
385
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
287
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
2308
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
2172
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1324
2026-04-22
【应用方向】TNFR蛋白家族概述
1304
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1501
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
1087
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
1123
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
1242
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
994
2026-04-20
【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量
14832
2026-03-02
【技术讲解】细胞因子科学选型--常见问题解答
11428
2026-09-21





